Positive Results for Experimental Parkinson's Treatment

The German pharmaceutical company "Bayer" confirmed today, Wednesday, that "initial tests on humans (over a year) have shown that the experimental stem cell treatment for Parkinson's disease has been well tolerated by patients, and the implanted cells remain alive in their brains." In a notable move, "Blue Rock Therapeutics" encouraged the development of the treatment testing on humans and its transition to the second phase out of three.